CSPC Financial Statements From 2010 to 2024
| CHJTF Stock | USD 0.67 0.16 19.28% |
Check CSPC Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CSPC Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . CSPC financial statements analysis is a perfect complement when working with CSPC Pharmaceutical Valuation or Volatility modules.
CSPC |
CSPC Pharmaceutical Group Company Operating Margin Analysis
CSPC Pharmaceutical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CSPC Pharmaceutical Operating Margin | 0.22 % |
Most of CSPC Pharmaceutical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CSPC Pharmaceutical Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, CSPC Pharmaceutical Group has an Operating Margin of 0.2214%. This is 100.63% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The operating margin for all United States stocks is 104.02% lower than that of the firm.
CSPC Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CSPC Pharmaceutical's current stock value. Our valuation model uses many indicators to compare CSPC Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CSPC Pharmaceutical competition to find correlations between indicators driving CSPC Pharmaceutical's intrinsic value. More Info.CSPC Pharmaceutical Group is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CSPC Pharmaceutical Group is roughly 1.77 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CSPC Pharmaceutical's earnings, one of the primary drivers of an investment's value.About CSPC Pharmaceutical Financial Statements
CSPC Pharmaceutical stakeholders use historical fundamental indicators, such as CSPC Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although CSPC Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. For example, changes in CSPC Pharmaceutical's assets and liabilities are reflected in the revenues and expenses on CSPC Pharmaceutical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CSPC Pharmaceutical Group. Please read more on our technical analysis and fundamental analysis pages.
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. Cspc Pharmaceuticals operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 25147 people.
Currently Active Assets on Macroaxis
Other Information on Investing in CSPC Pink Sheet
CSPC Pharmaceutical financial ratios help investors to determine whether CSPC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSPC with respect to the benefits of owning CSPC Pharmaceutical security.